ADAM WALLACE: Open Payments
NPI 1518129733 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 34 payments from 15 companies in 2025. Trend: 2023 $1,063 · 2024 $1,334 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $343 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| EBR SYSTEMS, INC. | 1 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Medtronic, Inc. | 3 | $66 |
| Valinor Pharma, LLC | 3 | $53 |
| Globus Medical, Inc. | 2 | $48 |
| Nalu Medical, Inc. | 1 | $46 |
| ABBVIE INC. | 2 | $45 |
| Averitas Pharma Inc. | 2 | $43 |
Products named: Intracept, Belbuca, RELISTOR, MOVANTIK, INTELLIS ADAPTIVESTIM, Senza, Nalu Neurostimulation System, BOTOX.
Industry payments across OK — which companies pay providers there.
